보고서 요약(국문)

개요
글로벌 DNA 마이크로어레이 시장은 2022년 XX백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) XX%로 성장하여 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
DNA 마이크로어레이는 특정 개인의 DNA에 BRCA1 및 BRCA2와 같은 유전자 변이가 있는지 여부를 확인하는 데 사용되는 도구입니다. 이 칩은 플라스틱으로 둘러싸인 작은 유리판으로 구성됩니다. 일부 기업은 컴퓨터 마이크로칩 제조에 사용되는 것과 유사한 방식으로 마이크로어레이를 생산합니다. DNA 마이크로어레이는 일부 질병에 대한 임상 진단 검사에 사용됩니다. 때로는 유전자가 우리 몸이 특정 약물과 관련된 화학 반응을 처리하는 방식을 결정하기 때문에 특정 개인에게 가장 적합한 약물을 결정하는 데에도 사용됩니다.

시장 동향: 성장 동인 및 제약 요인
주요 기업들의 전략적 이니셔티브 증가
정밀 의학 및 유전자형 분석 역량 개발을 위한 파트너십과 협력은 주요 경쟁업체들이 추진하는 전략적 활동 중 하나이며, 시장 확장을 위한 매력적인 기회를 제공할 것으로 예상됩니다.
예를 들어, 2022년 5월 카타르 게놈 프로그램(Qatar Genome Program)과 써모 피셔 사이언티픽(Thermo Fisher Scientific)은 카타르에서 유전체 연구 및 예측 유전체학의 임상 적용을 가속화하기 위한 파트너십을 발표했습니다. 이 파트너십은 중동 전역으로 정밀 의학의 이점을 확대했습니다. 또한, 예측 유전체학의 임상 적용을 강화하기 위해 설계된 맞춤형 유전자형 분석 어레이를 포함합니다.
뿐만 아니라, 암 발병률 증가, 빠르게 발전하는 정보 및 소프트웨어 기술, 그리고 새롭게 부상하는 생물정보학 등 다양한 요인들이 전 세계 DNA 마이크로어레이 시장 성장을 견인할 것으로 예상됩니다. 더불어, 연구 활동의 증가와 유전자 발현 분석에 DNA 마이크로어레이 사용이 늘어나는 것도 세계 시장 성장을 촉진하는 요인입니다.

시장 동향: 제약 요인
시장 성장을 저해하는 주요 제약 요인 중 하나는 DNA 시퀀싱과 관련된 높은 비용입니다. DNA 마이크로어레이는 유전자 발현 및 유전적 변이에 대한 귀중한 정보를 제공하지만, 시퀀싱 절차에 소요되는 비용은 상당할 수 있습니다. 이 비용에는 마이크로어레이 기술 자체의 구매 비용뿐만 아니라 샘플 준비, 데이터 분석 및 정교한 장비 유지 관리 관련 비용도 포함됩니다.
세분화 분석
글로벌 DNA 마이크로어레이 시장은 제품 유형, 종류, 응용 분야, 최종 사용자 및 지역별로 세분화됩니다.
제품 유형 부문 중 소모품은 DNA 마이크로어레이 시장 점유율의 약 43.5%를 차지했습니다.
소모품은 제품 유형 부문에서 약 43.5%를 차지하며 예측 기간 동안 시장을 주도할 것으로 예상됩니다. 소모품은 DNA 마이크로어레이 실험에서 중요한 역할을 합니다. 이 부문에는 어레이, 시약, 완충액 및 기타 필수 소모품과 같이 DNA 마이크로어레이 실험에 필요한 다양한 구성 요소가 포함됩니다. 이러한 소모품은 실험 성공에 필수적이며 DNA 마이크로어레이 슬라이드 인쇄, 하이브리드화 및 형광 기반 검출 시스템과 같은 공정에 사용됩니다.
지역 분석
북미는 2022년 시장 점유율의 약 38.4%를 차지했습니다.
북미는 주요 시장 참여 기업들의 존재와 기술적으로 진보된 DNA 마이크로어레이 제품 개발에 대한 투자 증가로 인해 예측 기간 동안 전체 시장 점유율의 약 38.4%를 차지할 것으로 예상됩니다.
또한 유전체학 분야의 기술 발전과 최첨단 연구 시설에 대한 접근성 향상은 시장 참여 기업들에게 기하급수적인 성장 기회를 제공할 것으로 예상됩니다. 더불어 학술 연구실에서부터 바이오 제약 회사에 이르기까지 연구 환경 전반에 걸쳐 DNA 마이크로어레이 기술의 높은 도입률은 이 지역의 성장을 더욱 가속화하고 있습니다.

북미는 예측 기간 동안 전체 시장 점유율의 약 38.4%를 차지할 것으로 예상됩니다. 예를 들어, 2023년 1월 NCBI는 이리노테칸 염산염 치료 대상 환자의 임상 검사에서 사용할 수 있는 UDP-글루쿠로노실트랜스퍼라제 유전자 다형성 검출용 마이크로어레이 시스템 개발을 발표했습니다. 이 시스템은 고밀도 및 DNA 고정 임상 응용 분야를 위한 측정 시스템 구축을 가능하게 합니다.
COVID-19 영향 분석
COVID-19 팬데믹은 COVID-19 환자 치료에 마이크로어레이를 활용한 연구 개발 활동 증가로 인해 전 세계 DNA/유전자 마이크로어레이 시장에 긍정적인 영향을 미쳤습니다.

시장 세분화
제품 유형별
• 소모품
• 기기
• 키트
유형별
• 상보적 DNA 마이크로어레이
• 올리고 DNA 마이크로어레이
• BAC 마이크로어레이
• SNP 마이크로어레이
응용 분야별
• 유전자 발현 분석
• 유전자형 분석
• 전사 인자 결합 분석
• 기타
최종 사용자별
• 제약 및 생명공학 회사
• 진단 센터
• 병원
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
시장의 주요 글로벌 업체로는 Thermo Fisher Scientific Inc., QIAGEN, Illumina, Inc., Agilent Technologies 등이 있습니다. Inc., Arrayit Corporation, PerkinElmer, Inc., Toray Group, Microarrays Inc., Twist Bioscience Corporation, Arraylt Corporation 등이 주요 기업입니다.

주요 개발 사항
 2023년 1월 15일, 미국 국립생명공학정보센터(NCBI)는 이리노테칸 염산염 치료 대상 환자의 임상 검사에서 UDP-글루쿠로노실트랜스퍼라제 유전자 다형성을 검출하는 마이크로어레이 시스템 개발을 발표했습니다. 이 시스템은 고밀도 및 DNA 고정 임상 적용을 위한 측정 시스템 구축을 가능하게 합니다.

 2022년 5월, 카타르 게놈 프로그램(Qatar Genome Program)과 진단 솔루션 제공업체인 Thermo Fisher Scientific은 카타르에서 유전체 연구 및 예측 유전체학의 임상 적용을 가속화하기 위한 파트너십을 발표했습니다.

보고서 구매 이유

• 제품 유형, 종류, 응용 분야, 최종 사용자 및 지역별 글로벌 DNA 마이크로어레이 시장 세분화를 시각화하고 주요 상업 자산 및 기업을 파악하기 위함입니다.

• 트렌드 분석 및 공동 개발을 통해 상업적 기회를 파악합니다.

• 모든 세그먼트를 포함한 DNA 마이크로어레이 시장 수준의 다양한 데이터가 담긴 엑셀 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 자료를 엑셀 파일로 제공합니다.

글로벌 DNA 마이크로어레이 시장 보고서는 약 69개의 표, 70개의 그림, 183페이지 분량입니다.
주요 독자층 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자은행
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global DNA Microarray Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX % during the forecast period 2023-2030.
The DNA microarray is a tool used to determine whether the DNA from a particular individual contains a mutation in genes like BRCA1 and BRCA2. The chip consists of a small glass plate encased in plastic. Some companies manufacture microarrays using methods similar to those used to make computer microchips. DNA microarrays are used in clinical diagnostic tests for some diseases. Sometimes they are also used to determine which drugs might be best prescribed for particular individuals because genes determine how our bodies handle the chemistry related to those drugs.
Market Dynamics: Drivers and Restraints
Rise in strategic initiatives by the key players
Partnerships and collaborations to develop precision medicine and genotyping capabilities are among the strategic activities done by the leading competitors and are projected to provide attractive opportunities for expansion for the market.
For instance, in May 2022, Qatar Genome Program and Thermo Fisher Scientific announced a partnership to accelerate genomic research and clinical applications of predictive genomics in Qatar. This partnership expanded the advantages of precision medicine across the Middle East. Moreover, it comprises custom genotyping arrays designed to boost clinical applications of predictive genomics.
Furthermore, the DNA microarray market is also driven by various other factors like the rising prevalence of cancer, the rapidly evolving information & software technology, and emerging bioinformatics are the factors likely to drive the global DNA microarray market. In addition, the surge in research activities and the rising use of DNA microarray in gene expression fuel the global market growth.
Market Dynamics: Restraint
One of the significant restraints hampering the growth of the market is the high cost associated with DNA sequencing. While DNA microarrays offer valuable insights into gene expression and genetic variations, the expenses incurred during sequencing procedures can be substantial. This cost comprises not only the acquisition of the microarray technology itself but also the expenses related to sample preparation, data analysis and maintenance of sophisticated equipment.
Segment Analysis
The global DNA Microarray market is segmented based on product type, type, application, end-user and region.
The Consumables from the product type segment accounted for approximately 43.5% of the DNA Microarray market share
The consumables from the product type segment accounted for approximately 43.5% and is expected to dominate during the forecast period. The consumables play a crucial role in DNA microarray experiments. This segment includes various components necessary for DNA microarray experiments, such as arrays, reagents, buffers, and other essential consumables. These consumables are vital for the success of the experiments and are used in processes such as printing DNA microarray slides, hybridization, and fluorescence-based detection systems.
Geographical Analysis
North America accounted for approximately 38.4% of the market share in 2022
North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to the presence of leading market players in the region and rising investments by them in developing technologically advanced DNA microarray products.
Moreover, technological advancements in genomics and access to modern research facilities are likely to create exponential growth opportunities for the players. Also, the high adoption of DNA microarray technology across research settings, from academic laboratories to biopharmaceutical companies, is further escalating the region’s growth.
For instance, in January 2023, the NCBI announced the development of a microarray system to detect UDP-glucuronosyltransferase gene polymorphisms for use in clinical laboratories in patients eligible for irinotecan hydrochloride treatment. It allows the construction of a measurement system for high-density and DNA fixation clinical applications.
COVID-19 Impact Analysis
The COVID-19 pandemic had a positive impact on the global DNA/gene microarray market, owing to increased research and development activities using arrays in the treatment of patients suffering from COVID-19.
Market Segmentation
By Product Type
• Consumables
• Instruments
• Kits
By Type
• Complementary DNA microarrays
• Oligo DNA microarrays
• BAC microarrays
• SNP microarrays
By Application
• Gene Expression Analysis
• Genotyping
• Transcription Factor Binding Analysis
• Others
By End User
• Pharmaceutical and Biotechnology Companies
• Diagnostic Centers
• Hospitals
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Thermo Fisher Scientific Inc., QIAGEN, Illumina, Inc., Agilent Technologies, Inc., Arrayit Corporation, PerkinElmer, Inc., Toray Group, Microarrays Inc., Twist Bioscience Corporation, Arraylt Corporation among others.
Key Developments
 On January 15, 2023, National Center for Biotechnology Information, announced the development of a microarray system to detect UDP-glucuronosyltransferase gene polymorphisms for use in clinical laboratories in patients eligible for irinotecan hydrochloride treatment. It allows the construction of a measurement system for high-density and DNA fixation clinical applications.
 In May 2022, Qatar Genome Program, a research institute, and Thermo Fisher Scientific, a provider of diagnostic solutions, announced a partnership to accelerate genomic research and clinical applications of predictive genomics in Qatar.

Why Purchase the Report?
• To visualize the global DNA microarray market segmentation based on product type, type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of DNA microarray market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global DNA microarray market report would provide approximately 69 tables, 70 figures and 183 pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Type
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region
4. Market Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in strategic initiatives by the key players
4.1.1.2. Rise in the advancement in DNA microarrays
4.1.2. Restraints
4.1.2.1. High cost associated with the DNA sequencing
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Consumables*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Instruments
7.4. Kits
8. By Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
8.1.2. Market Attractiveness Index, By Type
8.2. Complementary DNA microarrays*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Oligo DNA Microarrays
8.4. BAC microarrays
8.5. SNP microarrays
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Gene Expression Analysis*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Genotyping
9.4. Transcription Factor Binding Analysis
9.5. Others
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Pharmaceutical and Biotechnology Companies*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Diagnostic Centers
10.4. Hospitals
10.5. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.6.1. China
11.5.6.2. India
11.5.6.3. Japan
11.5.6.4. Australia
11.5.6.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Thermo Fisher Scientific, Inc*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. QIAGEN
13.3. Illumina, Inc
13.4. Agilent Technologies, Inc
13.5. Arrayit Corporation
13.6. PerkinElmer, Inc
13.7. Toray Group
13.8. Microarrays Inc
13.9. Twist Bioscience Corporation
13.10. Arraylt Corporation
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

Thermo Fisher Scientific, Inc, 4.	Key Developments, QIAGEN, Illumina, Inc, Agilent Technologies, Inc, Arrayit Corporation, PerkinElmer, Inc, Toray Group, Microarrays Inc, Twist Bioscience Corporation, Arraylt Corporation

표 목록 (Tables)

List of Tables

Table 1 Global DNA Microarray Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 2 Global DNA Microarray Market Value, By Type, 2023, 2027 & 2031 (US$ Million)

Table 3 Global DNA Microarray Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 4 Global DNA Microarray Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 5 Global DNA Microarray Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 6 Global DNA Microarray Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 7 Global DNA Microarray Market Value, By Product Type, 2022-2031 (US$ Million)

Table 8 Global DNA Microarray Market Value, By Type, 2023, 2027 & 2031 (US$ Million)

Table 9 Global DNA Microarray Market Value, By Type, 2022-2031 (US$ Million)

Table 10 Global DNA Microarray Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 11 Global DNA Microarray Market Value, By Application, 2022-2031 (US$ Million)

Table 12 Global DNA Microarray Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 13 Global DNA Microarray Market Value, By End User, 2022-2031 (US$ Million)

Table 14 Global DNA Microarray Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 15 Global DNA Microarray Market Value, By Region, 2022-2031 (US$ Million)

Table 16 North America DNA Microarray Market Value, By Product Type, 2022-2031 (US$ Million)

Table 17 North America DNA Microarray Market Value, By Type, 2022-2031 (US$ Million)

Table 18 North America DNA Microarray Market Value, By Application, 2022-2031 (US$ Million)

Table 19 North America DNA Microarray Market Value, By End User, 2022-2031 (US$ Million)

Table 20 North America DNA Microarray Market Value, By Country, 2022-2031 (US$ Million)

Table 21 South America DNA Microarray Market Value, By Product Type, 2022-2031 (US$ Million)

Table 22 South America DNA Microarray Market Value, By Type, 2022-2031 (US$ Million)

Table 23 South America DNA Microarray Market Value, By Application, 2022-2031 (US$ Million)

Table 24 South America DNA Microarray Market Value, By End User, 2022-2031 (US$ Million)

Table 25 South America DNA Microarray Market Value, By Country, 2022-2031 (US$ Million)

Table 26 Europe DNA Microarray Market Value, By Product Type, 2022-2031 (US$ Million)

Table 27 Europe DNA Microarray Market Value, By Type, 2022-2031 (US$ Million)

Table 28 Europe DNA Microarray Market Value, By Application, 2022-2031 (US$ Million)

Table 29 Europe DNA Microarray Market Value, By End User, 2022-2031 (US$ Million)

Table 30 Europe DNA Microarray Market Value, By Country, 2022-2031 (US$ Million)

Table 31 Asia-Pacific DNA Microarray Market Value, By Product Type, 2022-2031 (US$ Million)

Table 32 Asia-Pacific DNA Microarray Market Value, By Type, 2022-2031 (US$ Million)

Table 33 Asia-Pacific DNA Microarray Market Value, By Application, 2022-2031 (US$ Million)

Table 34 Asia-Pacific DNA Microarray Market Value, By End User, 2022-2031 (US$ Million)

Table 35 Asia-Pacific DNA Microarray Market Value, By Country, 2022-2031 (US$ Million)

Table 36 Middle East & Africa DNA Microarray Market Value, By Product Type, 2022-2031 (US$ Million)

Table 37 Middle East & Africa DNA Microarray Market Value, By Type, 2022-2031 (US$ Million)

Table 38 Middle East & Africa DNA Microarray Market Value, By Application, 2022-2031 (US$ Million)

Table 39 Middle East & Africa DNA Microarray Market Value, By End User, 2022-2031 (US$ Million)

Table 40 Thermo Fisher Scientific, Inc.: Overview

Table 41 Thermo Fisher Scientific, Inc.: Product Portfolio

Table 42 Thermo Fisher Scientific, Inc.: Key Developments

Table 43 QIAGEN.: Overview

Table 44 QIAGEN.: Product Portfolio

Table 45 QIAGEN.: Key Developments

Table 46 Illumina, Inc.: Overview

Table 47 Illumina, Inc.: Product Portfolio

Table 48 Illumina, Inc.: Key Developments

Table 49 Agilent Technologies, Inc.: Overview

Table 50 Agilent Technologies, Inc.: Product Portfolio

Table 51 Agilent Technologies, Inc.: Key Developments

Table 52 Arrayit Corporation: Overview

Table 53 Arrayit Corporation: Product Portfolio

Table 54 Arrayit Corporation: Key Developments

Table 55 PerkinElmer, Inc.: Overview

Table 56 PerkinElmer, Inc.: Product Portfolio

Table 57 PerkinElmer, Inc.: Key Developments

Table 58 Toray Group: Overview

Table 59 Toray Group: Product Portfolio

Table 60 Toray Group: Key Developments

Table 61 Microarrays Inc: Overview

Table 62 Microarrays Inc: Product Portfolio

Table 63 Microarrays Inc: Key Developments

Table 64 Twist Bioscience Corporation: Overview

Table 65 Twist Bioscience Corporation: Product Portfolio

Table 66 Twist Bioscience Corporation: Key Developments

Table 67 Arraylt Corporation: Overview

Table 68 Arraylt Corporation: Product Portfolio

Table 69 Arraylt Corporation: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 2 Global DNA Microarray Market Share, By Product Type, 2022 & 2031 (%)

Figure 3 Global DNA Microarray Market Share, By Type, 2022 & 2031 (%)

Figure 4 Global DNA Microarray Market Share, By Application, 2022 & 2031 (%)

Figure 5 Global DNA Microarray Market Share, By End User, 2022 & 2031 (%)

Figure 6 Global DNA Microarray Market Share, By Region, 2022 & 2031 (%)

Figure 7 Global DNA Microarray Market Y-o-Y Growth, By Product Type, 2022-2031 (%)

Figure 8 Consumables DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 9 Instruments DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 10 Kits DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 11 Global DNA Microarray Market Y-o-Y Growth, By Type, 2022-2031 (%)

Figure 12 Complementary DNA microarrays Type in Global DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 13 Oligo DNA microarrays Type in Global DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 14 BAC microarrays Type in Global DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 15 SNP microarrays Type in Global DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 16 Global DNA Microarray Market Y-o-Y Growth, By Application, 2022-2031 (%)

Figure 17 Gene Expression Analysis Application in Global DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 18 Genotyping Application in Global DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 19 Transcription Factor Binding Analysis Application in Global DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 20 Others Application in Global DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 21 Global DNA Microarray Market Y-o-Y Growth, By End User, 2022-2031 (%)

Figure 22 Pharmaceutical and Biotechnology Companies End User in Global DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 23 Diagnostic Centers End User in Global DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 24 Hospitals End User in Global DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 25 Others End User in Global DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 26 Global DNA Microarray Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 27 North America DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 28 Asia-Pacific DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 29 Europe DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 30 South America DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 31 Middle East and Africa DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 32 North America DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 33 North America DNA Microarray Market Share, By Product Type, 2022 & 2031 (%)

Figure 34 North America DNA Microarray Market Share, By Type, 2022 & 2031 (%)

Figure 35 North America DNA Microarray Market Share, By Application, 2022 & 2031 (%)

Figure 36 North America DNA Microarray Market Share, By End User, 2022 & 2031 (%)

Figure 37 North America DNA Microarray Market Share, By Country, 2022 & 2031 (%)

Figure 38 South America DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 39 South America DNA Microarray Market Share, By Product Type, 2022 & 2031 (%)

Figure 40 South America DNA Microarray Market Share, By Type, 2022 & 2031 (%)

Figure 41 South America DNA Microarray Market Share, By Application, 2022 & 2031 (%)

Figure 42 South America DNA Microarray Market Share, By End User, 2022 & 2031 (%)

Figure 43 South America DNA Microarray Market Share, By Country, 2022 & 2031 (%)

Figure 44 Europe DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 45 Europe DNA Microarray Market Share, By Product Type, 2022 & 2031 (%)

Figure 46 Europe DNA Microarray Market Share, By Type, 2022 & 2031 (%)

Figure 47 Europe DNA Microarray Market Share, By Application, 2022 & 2031 (%)

Figure 48 Europe DNA Microarray Market Share, By End User, 2022 & 2031 (%)

Figure 49 Europe DNA Microarray Market Share, By Country, 2022 & 2031 (%)

Figure 50 Asia-Pacific DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 51 Asia-Pacific DNA Microarray Market Share, By Product Type, 2022 & 2031 (%)

Figure 52 Asia-Pacific DNA Microarray Market Share, By Type, 2022 & 2031 (%)

Figure 53 Asia-Pacific DNA Microarray Market Share, By Application, 2022 & 2031 (%)

Figure 54 Asia-Pacific DNA Microarray Market Share, By End User, 2022 & 2031 (%)

Figure 55 Asia-Pacific DNA Microarray Market Share, By Country, 2022 & 2031 (%)

Figure 56 Middle East & Africa DNA Microarray Market Value, 2022-2031 (US$ Million)

Figure 57 Middle East & Africa DNA Microarray Market Share, By Product Type, 2022 & 2031 (%)

Figure 58 Middle East & Africa DNA Microarray Market Share, By Type, 2022 & 2031 (%)

Figure 59 Middle East & Africa DNA Microarray Market Share, By Application, 2022 & 2031 (%)

Figure 60 Middle East & Africa DNA Microarray Market Share, By End User, 2022 & 2031 (%)

Figure 61 Thermo Fisher Scientific, Inc.: Financials

Figure 62 QIAGEN.: Financials

Figure 63 Illumina, Inc.: Financials

Figure 64 Agilent Technologies, Inc.: Financials

Figure 65 Arrayit Corporation: Financials

Figure 66 PerkinElmer, Inc.: Financials

Figure 67 Toray Group: Financials

Figure 68 Microarrays Inc: Financials

Figure 69 Twist Bioscience Corporation: Financials

Figure 70 Arraylt Corporation: Financials

글로벌 DNA 마이크로어레이 시장 – 2023-2030

Global DNA Microarray Market - 2023-2030